Literature DB >> 708025

Combined activity of minocycline and amphotericin B in vitro against medically important yeasts.

M A Lew, K M Beckett, M J Levin.   

Abstract

The capacity of minocycline to enhance the activity of amphotericin B against Candida albicans, Torulopsis glabrata, Cryptococcus neoformans, and non-albicans Candida was examined in vitro utilizing a time-killing curve technique. Synergism was apparent at 4 h with 5 of 5 strains of C. albicans, 8 of 8 strains of C. neoformans, and 1 of 12 strains of non-albicans Candida. Synergism was apparent at 24 h with the remaining 11 strains of non-albicans Candida and all 5 strains of T. glabrata. C. neoformans was the most susceptible of the yeasts to the minocycline-amphotericin B combination; seven strains showed a 3-log or greater reduction in colony count in 4 h and all strains showed this reduction in 24 h at amphotericin B concentrations of 0.4 mug/ml or less in the presence of minocycline.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708025      PMCID: PMC352483          DOI: 10.1128/AAC.14.3.465

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  AMPHOTERICIN B TOXICITY; CHANGES IN RENAL MORPHOLOGY.

Authors:  G J HILL
Journal:  Ann Intern Med       Date:  1964-08       Impact factor: 25.391

2.  Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis.

Authors:  M Huppert; S H Sun; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

3.  Absorption and excretion of five tetracycline analogues in normal young men.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-05       Impact factor: 2.378

4.  A pharmacologic guide to the clinical use of amphotericin B.

Authors:  D D Bindschadler; J E Bennett
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

5.  New medium for in vitro susceptibility studies with amphotericin B.

Authors:  C J Utz; S White; S Shadomy
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

6.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

7.  Inhibitors of protein synthesis by ribosomes of the 80-S type.

Authors:  E Battaner; D Vazquez
Journal:  Biochim Biophys Acta       Date:  1971-12-16

8.  Bioassay for hamycin and amphotericin B in serum and other biological fluids.

Authors:  S Shadomy; J A McCay; S I Schwartz
Journal:  Appl Microbiol       Date:  1969-04

9.  Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  Potentiation of the antifungal effects of antibiotics by amphotericin B.

Authors:  C N Kwan; G Medoff; G S Kobayashi; D Schlessinger; H J Raskas
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191

View more
  6 in total

1.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

Review 4.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

5.  Novel synergism of two antifungal agents, copiamycin and imidazole.

Authors:  J Uno; M L Shigematsu; T Arai
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

6.  Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris Using an Inkjet Printer-Assisted Method.

Authors:  Thea Brennan-Krohn; Liam Friar; Sarah Ditelberg; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.